[Analysis of antibacterial activity of a new antiseptic for the treatment of maxillofacial inflammations].
Clinical and experimental studies of polydimethyldiallylammonium chloride (PDMDAAC) were carried out in order to select the optimal concentration and composition of the preparation. 1% PDMDAAC solution showed high antiseptic activity and can be used for local therapy of the periodontal inflammations and infected posttraumatic wounds.
Kuznetsova
L I
LI
Leshchankina
E L
EL
Kuznetsov
B L
BL
D001424:Bacterial Infections / Q000188:drug therapy; D002177:Candidiasis / Q000188:drug therapy; D005151:Facial Injuries / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D010518:Periodontitis / Q000188:drug therapy / Q000382:microbiology*; D011095:Polyethylenes / Q000627:therapeutic use*; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use*; D013501:Surface-Active Agents / Q000627:therapeutic use*; D014945:Wound Healing / Q000187:drug effects; D014946:Wound Infection / Q000188:drug therapy* / Q000382:microbiology
D011095:Polyethylenes; D000644:Quaternary Ammonium Compounds; D013501:Surface-Active Agents; C041004:poly-N,N-dimethyl-N,N-diallylammonium chloride